First Patient Dosed in CANbridge Pharmaceuticals CAN103 Phase 1/2 Trial for the Treatment of Gaucher Disease in China
– Peking Union Medical College Hospital Primary Clinical Trial Site BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge…
– Peking Union Medical College Hospital Primary Clinical Trial Site BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge…
MEDFORD, Ore.–(BUSINESS WIRE)–PBCO Financial Corporation (OTC PINK: PBCO), the holding company of People’s Bank of…
CAMBRIDGE, Mass., July 20, 2022 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading…
Monthly information regarding the total number of voting rights and total number of shares of…
Company now focused on advancing lead clinical candidate mavorixafor in chronic neutropenic disorders, including WHIM syndrome…
Triple combination clinical trial evaluating AB-729, an RNAi therapeutic, vebicorvir, Assembly Biosciences’ core inhibitor, and…
DUBLIN, Ireland and FORT WASHINGTON, Pa., July 20, 2022 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc…
– Discontinues clinical development of vebicorvir, Assembly Bio’s first-generation core inhibitor, based on interim efficacy…
FREMONT, Calif., July 20, 2022 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”)…
Pan-Ig and HBGA blocking antibody responses persisted to year 5 No adverse events deemed related…
Easy, intuitive toolkit for Decentralized Autonomous Organizations suits the needs of businesses, technology teams and…
Toronto, Ontario and New York, New York–(Newsfile Corp. – July 20, 2022) – Micromem Technologies…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases research that examines how the transition from fossil fuels to sustainable…
WESTWOOD, Mass.–(BUSINESS WIRE)–Chase Corporation (NYSE American: CCF), a global specialty chemicals company that is a…
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA assigns preliminary ratings to a term bond issued by New York State…
HAMILTON, Bermuda–(BUSINESS WIRE)–Assured Guaranty Ltd. (NYSE: AGO)(the Company) today announced that it will issue its…
Additional Strategic Development includes Equity Investment by Titanium Industry Veteran LONDON–(BUSINESS WIRE)–Fodere Titanium Limited (“Fodere”)…
Highlights for the second quarter include: Quarterly net income of $9.5 million, compared to $11.2…
Expects to Exceed Prior Financial Guidance SAN JOSE, Calif.–(BUSINESS WIRE)–Super Micro Computer, Inc. (Nasdaq: SMCI),…
MEDINA, Ohio–(BUSINESS WIRE)–RPM International Inc. (NYSE: RPM) today announced that Bryan R. Gillette has been…